About us
- >
- About us >
- Information >
- Announcement
2018-01-11
The US 858, 954 patent is granted.
The US patent, method for treating disease or condition susceptible to ameliorationby AMPK activators and compounds of formula which are useful to activateAMP-activated protein kinase (AMPK) (13/858,954), is granted since we applied to USPTO in 2013.
Pattern covers the medical indications using the ENRGI platform, such as treatments of wound healing, metabolic disorders and others.